Intervention program prevents smoking relapse, increases breastfeeding duration

NewsGuard 100/100 Score

New mothers who smoke are less likely to breastfeed. But those who quit smoking during or just prior to becoming pregnant were significantly more likely to remain smoke free and continue breastfeeding if they received support and encouragement during the first eight weeks following child birth, according to a study presented Monday, Oct. 4, at the American Academy of Pediatrics (AAP) National Conference and Exhibition in San Francisco.

Mothers who smoke are more than twice as likely to quit breastfeeding before their child is 10 weeks old, and more than 50 percent of mothers who quit smoking during their pregnancy, begin smoking again, usually two to eight weeks postpartum.

In the study, "Increasing the Duration of Breastfeeding by Preventing Postpartum Smoking Relapse," mothers who had quit smoking during or just prior to pregnancy, and had babies admitted to the Neonatal Intensive Care Unit (NICU), were placed into two groups: a "relapse prevention" group and a "standard of care" group. Both groups of mothers received information about the importance of providing a smoke-free environment for their baby and breastfeeding support. Because stress is a major factor in smoking relapse, the mothers in the intervention group also received information about newborn behaviors, and were encouraged to have frequent skin-to-skin contact with their babies, fostering mother-infant bonding in the NICU.

At the end of eight weeks postpartum, 82 percent of mothers in the intervention group remained smoke free and 86 percent continued to breastfeed. In the standard of care group, 44 percent of mothers were smoke free after eight weeks, and only 7 percent continued to breastfeed.

"By decreasing secondhand smoking exposure and increasing breastfeeding duration, both of which have well documented short- and long-term benefits, this intervention can make a significant contribution to the health of infants and their mothers," said Raylene Phillips, MD, FAAP, lead author of the study, who presented the research results at the AAP conference.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Risk factors for serious inflammatory conditions in IBD patients identified